Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 9, 2012, Pages 814-822

  Oka, Rie ^a   Yagi, Kunimasa ^b   Sakurai, Masaru ^c   Nakamura, Koshi ^c   Nagasawa, Shin ya ^c   Miyamoto, Susumu ^a   Nohara, Atsushi ^b   Kawashiri, Masa aki ^b   Hayashi, Kenshi ^b   Takeda, Yoshiyu ^b   Yamagishi, Masakazu ^b  

^a Hokuriku Central Hospital   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Insulin resistance; Obesity; Visceral adipose tissue

Indexed keywords

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; JAPANESE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; SEX DIFFERENCE; SUBCUTANEOUS TISSUE; WAIST CIRCUMFERENCE;

ASIAN CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; BODY MASS INDEX; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED; WAIST CIRCUMFERENCE;

EID: 84867903410     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.12294     Document Type: Article

References (42)

1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama, 2003; 289: 76-79
2. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Despres JP: Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation, 2000; 102: 179-184
3. Harris MM, Stevens J, Thomas N, Schreiner P, Folsom AR: Associations of fat distribution and obesity with hypertension in a bi-ethnic population: the ARIC study. Atherosclerosis Risk in Communities Study. Obes Res, 2000; 8: 516-524
4. Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature, 2006; 444: 881-887
5. Van Gaal LF, Mertens IL, De Block CE: Mechanisms linking obesity with cardiovascular disease. Nature, 2006; 444: 875-880
6. McLaughlin T, Abbasi F, Lamendola C, Reaven G: Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med, 2007; 167: 642-648
7. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med, 2008; 168: 1617-1624
8. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G: Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism, 2004; 53: 495-499
9. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest, 1997; 100: 1166-1173
10. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol, 2008; 28: 1039-1049
11. Bjorntorp P: "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis, 1990; 10: 493-496
12. Hutley L, Prins JB: Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci, 2005; 330: 280-289
13. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S: Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol, 2005; 288: H2031-2041
14. Kishida K KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I: Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb, 2011; 18: 592-595
15. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L: Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care, 2000; 23: 465-471
16. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY: Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care, 2003; 26: 650-655
17. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, Shofer JB, Fish BE, Knopp RH, Kahn SE: Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes, 2004; 53: 2087-2094
18. Brochu M, Starling RD, Tchernof A, Matthews DE, Garcia-Rubi E, Poehlman ET: Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab, 2000; 85: 2378-2384
19. Gan SK, Kriketos AD, Poynten AM, Furler SM, Thompson CH, Kraegen EW, Campbell LV, Chisholm DJ: Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res, 2003; 11: 1295-1305
20. Ross R, Freeman J, Hudson R, Janssen I: Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab, 2002; 87: 5044-5051
21. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM: Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest, 1995; 96: 88-98
22. Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A, Brixen K, Andersen M: Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab, 2009; 94: 4010-4015
23. Tulloch-Reid MK, Hanson RL, Sebring NG, Reynolds JC, Premkumar A, Genovese DJ, Sumner AE: Both subcutaneous and visceral adipose tissue correlate highly with insulin resistance in african americans. Obes Res, 2004; 12: 1352-1359
24. Oka R, Miura K, Sakurai M, Nakamura K, Yagi K, Miyamoto S, Moriuchi T, Mabuchi H, Yamagishi M, Takeda Y, Hifumi S, Inazu A, Nohara A, Kawashiri MA, Kobayashi J: Comparison of waist circumference with body mass index for predicting abdominal adipose tissue. Diabetes Res Clin Pract, 2009; 83: 100-105
25. Kobayashi J, Tadokoro N, Watanabe M, Shinomiya M: A novel method of measuring intra-abdominal fat volume using helical computed tomography. Int J Obes Relat Metab Disord, 2002; 26: 398-402
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28: 412-419
27. DeFronzo RA, Matsuda M: Reduced time points to calculate the composite index. Diabetes Care, 2010; 33: e93
28. Thamer C, Machann J, Staiger H, Mussig K, Schwenzer N, Ludescher B, Machicao F, Claussen C, Fritsche A, Schick F, Stefan N, Haring HU: Interscapular fat is strongly associated with insulin resistance. J Clin Endocrinol Metab, 2010; 95: 4736-4742
29. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 1999; 22: 1462-1470
30. Lorenzo C, Haffner SM, Stancakova A, Laakso M: Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals. J Clin Endocrinol Metab, 2010; 95: 5082-5090
31. Hanley AJ, Wagenknecht LE, Norris JM, Bryer-Ash M, Chen YI, Anderson AM, Bergman R, Haffner SM: Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia, 2009; 52: 2079-2086
32. Kanaya AM, Harris T, Goodpaster BH, Tylavsky F, Cummings SR: Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. Diabetes Care, 2004; 27: 1375-1380
33. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH: Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab, 2000; 278: E941-948
34. Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA: Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab, 2002; 283: E1135-1143
35. Wagenknecht LE, Langefeld CD, Scherzinger AL, Norris JM, Haffner SM, Saad MF, Bergman RN: Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes, 2003; 52: 2490-2496
36. Sakamoto A, Ishizaka Y, Toda E, Nagai R, Koike K, Yamakado M, Ishizaka N: Impact of changes in obesity parameters on glucose metabolism and insulin resistance over a one-year period. J Atheroscler Thromb, 2010; 17: 1246-1255
37. Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E, Pi-Sunyer FX: Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr, 2008; 87: 1212-1218
38. McNeely MJ, Shofer JB, Leonetti DL, Fujimoto WY, Boyko EJ: Associations among visceral fat, all-cause mortality, and obesity-related mortality in Japanese Americans. Diabetes Care; 35: 296-298
39. McLaughlin T, Lamendola C, Liu A, Abbasi F: Preferential Fat Deposition in Subcutaneous Versus Visceral Depots Is Associated with Insulin Sensitivity. J Clin Endocrinol Metab, 2011; 96: E1756-1760
40. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS: Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care, 2009; 32: 1068-1075
41. Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, Irlbeck T, Meigs JB, Sutherland P, D'Agostino RB, Sr., O'Donnell CJ, Fox CS: Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring), 2010; 18: 2191-2198
42. Stancakova A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M: Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes, 2009; 58: 1212-1221